Article
08 Oct 2025
First Drug Patent Term Extension Granted In China
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in China
AUTHORS CONTENT
Article
25 Jul 2025
2026 Chinese Unfair Anti-Competition Law (UACL)
Article
02 May 2025
China SAMR Draft Trade Secret Protection Provision 2025
Article
27 Mar 2025
CN 2025 Drafts On Clinical Trial Data Exclusivity
Article
27 Mar 2025
China Requires Labelling Of Contents Generated By Artificial Intelligence From 1 Sep 2025
Article
10 Feb 2025
CN Final Antimonopoly Guidelines For The Pharmaceutical Sector
Article
07 Jan 2025
CNIPA Published Patent Licensing Data From 2019 To 2023
Article
06 Jan 2025
Comments To CN Draft Anti-Unfair Competition Law (2024), Deadline 20 January 2025
Article
02 Dec 2024
Two Updates From The CNIPA In Nov 2024 - Draft Government Procurement Requirements, And IP Statistics Public Enquiry Guidelines
Article
15 Nov 2024
SAMR Finalized "Anti-Monopoly Guidelines For Standard Essential Patents"
Article
01 Oct 2024
CNIPA's Drafts For Comments Of Patent And Trademark Agency Engagement Letters (Sep 2024)
Article
16 Aug 2024
CN SAMR Antitrust Guidelines For The Pharmaceutical Sector (Draft For Comments)
Article
29 May 2024
China's Experimental Attempts To Monetize Patents
Article
05 Jan 2024
CNIPA's Guidelines On The Distinctiveness Of Unconventional Trademarks
Article
04 Jan 2024
Chinese Patent Examination Guidelines 2023 – Toby's Observations
Article
02 Jan 2024
Christmas Present From China – Implementation Regulations (IMR) Of The Chinese Patent Law (2023)
Article
18 Dec 2023
Two CN IP Updates – CNIPA's Continuing Cracking Down On Malicious IP Agencies, And Shanghai Free Trade Zone (SFTZ) Opening-up Overall Plan
Article
08 Dec 2023
Released On 1 Dec 2023 - Draft Provisions On Standards On Evidence For Trademark
Article
31 Oct 2023
Yet Another Two CN IP Updates
Article
31 Oct 2023
Two IP Updates From China – Draft Regulations On Patent Firms Advertising, And For PCT Application Filed With CNIPA As The RO, Using EPO As ISA